Market Analysis and Insights: Global Human Growth Hormone Market

Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.

Due to the COVID-19 pandemic, the global Human Growth Hormone market size is estimated to be worth US$ 4455.2 million in 2022 and is forecast to a readjusted size of US$ 5645.8 million by 2029 with a CAGR of 3.4% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Powder accounting for % of the Human Growth Hormone global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Growth Hormone Deficiency (GHD) segment is altered to an % CAGR throughout this forecast period.

For industry structure analysis, the Human Growth Hormone industry is very concentrated. These manufacturers ranging from large multinational corporations to small privately owned companies compete in this industry. The top five producers include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono and F. Hoffmann-La Roche, account for more than 80% of the revenue market. Regionally, North America is the biggest production value area of valves, also the leader in the whole Human Growth Hormone industry.

North America occupied 42% of the production market. It is followed by Europe and China, which respectively have around 27% and 16% of the global total industry. Other countries have a small amount of production. Geographically, North America was the largest consumption market in the world, which took about 44.59% of the global consumption volume.

Global Human Growth Hormone Scope and Market Size

The global Human Growth Hormone market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Human Growth Hormone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.


Segment by Type


Powder

Solvent


Segment by Application


Growth Hormone Deficiency (GHD)

Turner Syndrome

Chronic Renal Insufficiency

Prader Willi Syndrome

Small for Gestational Age

SHOX Deficiency

Others

By Region

United States

Europe

China

Japan

Southeast Asia

India

Other Regions


By Company


Novo Nordisk

Pfizer

Eli Lilly

Merck Serono

F. Hoffmann-La Roche

Ferring Pharmaceuticals

GeneScience Pharmaceuticals

Ipsen

LG Life Sciences

Sandoz International

Anhui Anke Biotechnology